GLP-1 medications like Wegovy have transformed weight loss, but for many women, the experience goes beyond the scale
CMR with steady-state, free-precession sequences is considered the gold standard of cardiac chamber volumes (17)
Therefore, DPP4 inhibitors are commonly potential hypoglycemic agents.As reported, Saxagliptin (BMS-477118) is a potent, selective, reversible, competitive and orally active DPP-4 inhibitor (K i = 0.6-1.3 nM)
284 Emerging epigenetic data suggest that GLP-1 RAs may decelerate biological aging via DNA methylation modifications at loci associated with inflammatory and metabolic regulation, consistent with observed reductions in biological age
Pregnancy often involves weight gain, which could be a significant contributor to persistent obesity among females